![Patrick Crutcher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrick Crutcher
Directeur/Bestuurslid bij
JASPER THERAPEUTICS, INC.
Vermogen: 9 M $ op 30-09-2026
Profiel
Patrick J.
Crutcher was the founder of Mach5 Therapeutics, Inc., founded in 2024, where the title held was Chief Executive Officer & Director from 2024 to 2026.
Mr. Crutcher is also the founder of Helicore Biopharma, Inc.,AstralBio, Inc...
Mr. Crutcher currently serves as Independent Director at Amanat Acquisition Corp.
starting in 2026 and as Director at Jasper Therapeutics, Inc. starting in 2026.
Former positions include President & Chief Executive Officer at AlmataBio, Inc., Chairman & President at Ichorion Therapeutics, Inc. from 2017 to 2018, and Chief Strategy Officer at Avalo Therapeutics, Inc. in 2019.
Education includes graduate studies at the University of California, Los Angeles and undergraduate studies at the University of Illinois.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 06-08-2025 | 549.467 ( 1,02% ) | 8 M $ | 30-09-2026 | |
iBio, Inc.
 iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins 0,87% | 30-06-2025 | 300.438 ( 0,87% ) | 354 517 $ | 30-09-2026 |
| 10-08-2026 | 518.331 ( 1,56% ) | 300 632 $ | 30-09-2026 | |
| 20-07-2026 | 463.452 ( 9,98% ) | 268 802 $ | 30-09-2026 |
Actieve functies van Patrick Crutcher
| Bedrijven | Functie | Begin |
|---|---|---|
| JASPER THERAPEUTICS, INC. | Directeur/Bestuurslid | 16-07-2026 |
Eerdere bekende functies van Patrick Crutcher
| Bedrijven | Functie | Einde |
|---|---|---|
ValenzaBio, Inc.
 ValenzaBio, Inc. BiotechnologyHealth Technology Develops treatment options for patients with autoimmune and inflammatory diseases | Oprichter | 01-01-2023 |
| AVALO THERAPEUTICS, INC. | Corporate Officer/Principal | 01-11-2019 |
Ichorion Therapeutics, Inc.
 Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceutical products | Voorzitter | 01-09-2018 |
Opleiding van Patrick Crutcher
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
27
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois
 University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avalo Therapeutics, Inc.
 Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
Ichorion Therapeutics, Inc.
Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceutical products | Health Technology |
ValenzaBio, Inc.
ValenzaBio, Inc. BiotechnologyHealth Technology Develops treatment options for patients with autoimmune and inflammatory diseases | Health Technology |
Jasper Therapeutics, Inc.
 Jasper Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company which engages in enabling cures through hematopoietic stem cell therapy | Health Technology |
